|
Mem Inst Oswaldo Cruz, Rio de Janeiro, Mechanisms Mediating Antigenic Variation in Trypanosoma brucei Gloria Rudenko Wellcome Trust Centre for the Epidemiology of Infectious Disease, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, England Fax: +44-1865-281.245. Received 12 November 1998
Code Number:OC99046 Antigenic variation in Trypanosoma brucei is a highly sophisticated survival strategy involving switching between the transcription of one of an estimated thousand variant surface glycoprotein (VSG) genes. Switching involves either transcriptional control, resulting in switching between different VSG expression sites; or DNA rearrangement events slotting previously inactive VSG genes into an active VSG expression site. In recent years, considerable progress has been made in techniques allowing us to genetically modify infective bloodstream form trypanosomes. This is allowing us to reengineer VSG expression sites, and look at the effect on the mechanisms subsequently used for antigenic variation. We can now begin a dissection of a highly complicated survival strategy mediated by many different mechanisms operating simultaneously. Key words: antigenic variation - Trypanosoma brucei - variant surface glycoprotein (VSG) - VSG expression site MECHANISMS OF ANTIGENIC VARIATION African trypanosomes are effective pathogens, as they can establish chronic infections in man and his lifestock, despite being fully exposed to periodic assault by the immune system. Their survival strategy is based on ensuring that at a low frequency, trypanosomes arise which have changed the epitopes exposed on their surface. This exchangeable surface coat is a homogeneous layer composed of a single variant surface glycoprotein (VSG). As each individual trypanosome encodes up to a thousand VSG genes, and is capable of making chimaeric new ones, the potential for variation during a protracted infection is endless. Intense research by many laboratories in the eighties laid the basis for what is known about the main mechanisms of VSG switching in bloodstream form Trypanosoma brucei. Any given VSG coat is encoded by a single VSG gene transcribed in an expression site located at the ends of certain chromosomes. As there are 20 bloodstream form VSG expression sites, one way of switching is simply to silence the active expression site and activate a new one (an in situ switch). This method of switching accesses a relatively small pool of 20 VSG genes. However, recent evidence indicates that the different VSG expression sites each contain genes encoding receptor proteins that are optimized for different hosts (Bitter et al. 1998). This could mean that in situ switches are important during the establishment of the trypanosome in a new host species. VSG switching can also be mediated by DNA rearrangements like gene conversions or telomere exchange. Gene conversions access the largest pool of VSG genes (virtually all of them). A silent VSG gene is copied and inserted into the active expression site, replacing the old VSG gene. Alternatively, trypanosomes can switch via telomere exchange, whereby a silent VSG gene at a chromosome end is flipped into the active VSG expression site. Recent overviews of antigenic variation are Donelson (1995), Vanhamme and Pays (1995), Borst et al. (1996), Cross (1996), Barry (1997), Rudenko et al. (1998b). The problem with studying antigenic variation in the field has been that all of these mechanisms are operating at the same time, and antigenic populations of parasites within an animal are normally not monoclonal. The 20 VSG expression sites are highly similar with each other, with only the VSG gene as a unique marker. Once the VSG gene has been switched a few times, it can be very difficult to reconstruct how this has happened. Due to the polyclonal nature of the infection, it is also impossible to prove that trypanosomes present in various peaks are sequentially derived from each other. In contrast, single relapse experiments with laboratory strains are a highly simplified model system, which should give us insights into how antigenic variation is mediated in field strains. NEW METHODS TO STUDY VSG EXPRESSION SITE SWITCHING Methods developed recently at the Rockefeller University in New York allow the cloning of infective bloodstream form trypanosomes on agarose plates (Carruthers & Cross 1992) and their stable transfection (Carruthers et al. 1993). Cloned trypanosomes remain infective, and T. brucei populations cultured on agarose plates don't lose their pleomorphic phenotype (Vassella & Boshart 1996). These techniques are allowing us to genetically modify VSG expression sites, and look at the subsequent effect on the mechanisms used to mediate antigenic variation in bloodstream form trypanosomes. I will give a number of examples where recent experiments are making us reevaluate old hypotheses about how VSG expression site switching occurs. DNA transfection experiments that add or exchange promoters in expression sites, have shown us that VSG expression site control does not appear to require a specific promoter sequence. An rDNA promoter replacing the endogenous VSG expression site promoter can be switched on and off effectively (Rudenko et al. 1995). In addition, different non-homologous promoters inserted into various positions in the expression site are silenced essentially equally well (Horn & Cross 1995, 1997a,b). These results were unexpected, as it had been assumed that the specific sequence of the VSG expression site promoter was recognized by specific transcription factors which played a role in switching. This possibility now appears to be unlikely. During chronic infections a rough form of patterning is seen, as the switch from one VSG coat to another is not entirely random but can occur according to a rough pattern. It had been postulated that this ordered appearance of coats was due to the varying viabilities of different double expressing switch intermediates wearing different combinations of double VSG coats (Agur et al. 1989). Although this was an intriguing hypothesis, genetically modified trypanosomes have not supported it. Three different pairs of trypanosome strains reengineered to express a second additional VSG gene inserted in the active VSG expression site, though double VSG expressors, showed no growth disadvantage in rodents (Munoz-Jordan et al. 1996). Lastly, all known VSG expression sites contain characteristic arrays of 70 bp repeat sequences upstream of the telomeric VSG gene. A few of these repeats are also present upstream of chromosome internal basic copy VSG genes. It had been hypothesized that these 70 bp repeat sequences were the targets of a sequence specific endonuclease which generated a cut, allowing the gene conversion of a new VSG gene. If this were the case, then deleting the 70 bp repeat arrays from the active expression site should result in the drastic reduction of gene conversion reactions with the active expression site. This was shown not to be the case. Trypanosomes without 70 bp repeat arrays in the active expression site that were allowed to switch their VSG coat, underwent as many gene conversion reactions as wild type trypanosomes. As expected in these trypanosomes, the donor sequences were exclusively other expression sites rather than chromosome internal VSG genes (McCulloch et al. 1997). Therefore, no evidence was found that the 70 bp repeat sequences were a particular "hot spot" for gene conversion reactions. Genetic manipulation has also helped in the characterization of VSG expression sites. As the many VSG expression sites are almost identical to each other, selectable markers inserted into the promoter areas can be used as tags in the analysis of the expression site promoter region. Analysis of these marked expression sites after in situ switches have not shown detectable obligatory DNA rearrangements (Navarro & Cross 1996, Horn & Cross, 1997a, Rudenko et al. 1998a). In addition, the unique marker genes inserted have been used to probe the expression site promoter area for J, a unique DNA modification found in trypa-nosomatids (Van Leeuwen et al. 1997). Lastly, transfection experiments are being used to determine the function of the multiple expression site associated genes (ESAGs) present in the polycistronic VSG expression site transcription unit. Inactivating the ESAG1 gene in an active expression site, does not give a detectable phenotype (Carruthers et al. 1996). This could be due to the redundancy of multiple additional ESAG1 genes present in the genome. In short, the capacity to modify the trypanosome genome in vitro has revolutionized our ability to dissect apart something as complicated as antigenic variation in African trypanosomes. REFERENCES
Copyright 1999 Fundacao Oswaldo Cruz - Fiocruz |
|